You are on page 1of 7

in this lesson we'll cover the concept

of pharmacodynamics so while

pharmacokinetics describes the actions


of body on the drug pharmacodynamics

describes the opposite in other words in


the study of pharmacodynamics we look at

what a drug does to a body so when a


drug enters your body it then starts

interacting with cell receptors which in


turn leads to a formation of signal and

this signal through series of different


reactions ultimately results in some

biological effect so for example the


signal can tell DNA to stop replicating

cells in our body have lots and lots of


different receptors which when stimulated

can produce very unique responses the


receptors that have the most therapeutic

relevance can be divided into four types


number one ligand-gated ion channels

number two G protein-coupled receptors


number three enzyme-linked receptors and

number four intracellular receptors so


now let's talk about them in more

details let's start with ligand-gated


ion channel which is probably the

easiest one to describe out of the four


and just a quick reminder ligand

generally refers to some molecule or


an ion so this channel has a ligand

binding site and when the ligand binds


to it the channel opens very briefly

which allows ions such as sodium


potassium chloride calcium etc to pass

through the membrane and that's all it


is to it next we have G protein-coupled

receptor also known as seven-transmembrane receptor and this is

because it passes through the cell


membrane seven times so these receptors
are composed of three subunits alpha
beta and gamma all together known as

G protein in its inactive form the alpha


subunit has

GDP attached to it however when ligand


binds to the receptor the affinity for

GTP increases so then GTP replaces GDP


this in turn causes the alpha subunit to

dissociate from beta-gamma complex and then both of these complexes go to

interact with other enzymes or proteins


which they can alter and regulate

ultimately leading to some kind of


response now there are three kinds of

G proteins that are important to remember


these are Gs Gi and Gq first Gs is a

stimulative g-protein that activates


enzyme called adenylyl cyclase which

produces cyclic AMP from ATP cyclic


AMP is a very important second

messenger the second kind the Gi is an


inhibitory G protein which inhibits

adenylyl cyclase thus lowers levels of


cAMP in the cell

the last one is Gq which activates class


of enzymes called phospholipases C

we will refer to them as PLC now PLC


produces two second messengers first

diacylglycerol which we will refer to as DAG and the second one inositol

triphosphate which will refer to as IP3


now DAG just like cAMP leads to

different responses through activation


of protein kinases however IP3

produces various responses by mediating


intracellular release of calcium it's

also important to remember that G protein-coupled receptors as well as most

enzyme-linked receptors have ability to


amplify signals that they receive so for

example just one stimulated G protein


receptor can activate many adenylyl
cyclases which will result in more cyclic
AMP molecules produced and ultimately

amplified response now let's move on to


enzyme-linked receptors

these receptors just like G protein


receptors have extracellular binding

site where ligand typically hormone or


growth factor can attach and thus

stimulate enzymatic activity inside the cell

most enzyme-linked receptors are of tyrosine kinase type which simply means that
they

display kinase activity and that there


is a amino acid tyrosine involved in

that so the way it works is that when


ligand binds to two of these receptors

it causes conformational change that


results in aggregation of both

receptors once the dimer is formed the


tyrosine regions get activated and cause

ATP to become ADP which results in auto phosphorylation of the receptors now

once each tyrosine picks up phosphate


group different inactive intracellular

proteins come up and attach themselves


to phosphorylated tyrosine this in turn

causes conformational change in the


attached protein ultimately leading to

cascade of activations that produces


cellular response next and the last type

of receptor that I want to talk about is


intracellular receptor unlike the other

three this receptor is located entirely


inside the cell rather than on cells

membrane therefore the ligand has to


first cross lipid membrane and then once

it's inside it can then bind to the


receptor now the activated ligand

receptor complex can move into the


nucleus bind to DNA and regulate gene
expression ultimately leading to
synthesis of specific proteins now let's

briefly talk about life cycle of


receptors so each cell's DNA contains

code that's used to synthesize proteins


from which different receptors are

assembled once assembled the receptors


get embedded into the cell membrane and

can receive and respond to signaling


molecules but now let me ask you what

happens if cells receive too much


stimulation which can potentially damage

the cell well fortunately for us cells


have the ability to downregulate

receptors
meaning they can take them out of the

membrane and recycle them which leads to


fewer number of expressed receptors and

thus decreased sensitivity to signaling


molecules on the other hand let me ask

you what happens if most of cell's


receptors get blocked and cell receives

very weak signals well in that case


cells have the ability to upregulate

their receptors which means that more


receptors can get inserted into the

membrane thus increasing cell


sensitivity to signaling molecules now

let's look at the example where our


signaling molecule is actually some kind

of a drug so as the concentration of


that drug increases its pharmacologic

effect also increases until we reach the


point at which all the receptors are

occupied if we plot this we can


determine EC50 from the graph EC50 is

simply the concentration of a drug that


produces 50% of the maximal

effect and it tells us how potent the


drug is so let's call this curve drug "A"
now if we can graph dose response for a
different drug let's say drug "B" which

yields different curve we can now easily


tell that of the two drug "A" is more

potent because it has lower EC50 simply


less drug is needed to get half of the

max response now what else can we see on


this graph it looks like drug "B" doesn't

even reach the same level of


pharmacological effect as drug "A" and

this is due to its efficacy so maximum


efficacy of each drug is represented by

Emax at which we assume that all the


receptors are occupied by the drug and

higher concentrations of it don't


produce larger effect so in this example

drug "A" is not only more potent but also


more efficacious now let's talk about

intrinsic activity of drugs so intrinsic


activity refers to ability of a drug to

produce maximal effect so if a drug


binds to a receptor and is able to

produce
maximum effect that is comparable to

effect produced by our bodies own


endogenous ligand we call it a full

agonist now let's say about 15% of


receptors show some kind of activity

when there is no agonist around this is


what we call basal activity so again in

presence of full agonist we would see


maximal effect next if we have agonist

that is unable to produce maximal effect


even if it occupies all the receptors we

call partial agonist lastly if we have


an agent that binds to the receptors and

instead of activating them it stabilizes


receptors in their inactive form we call it

inverse agonist and this is because it


simply eliminates basal activity on the

other side of the spectrum we have


antagonist which refers to a ligand that

can bind to receptor and block it thus


reducing agonist activity so if we have

both agonist and antagonist that can


bind to the same side on the receptor

they will compete for that side


therefore antagonist

that binds and prevents agonist from


binding it's called competitive

antagonist the characteristic of


competitive antagonist is that it shifts

dose response curve of the agonist to the


right so for example if agonist is some

drug in the presence of competitive


antagonists we need higher

concentrations of that drug to get half


of the max effect which is EC50 so

potency is reduced now some antagonists


can form covalent bonds with active site

on the receptor and thus irreversibly


block it

this is non-competitive process because


irreversible antagonists can't be

displaced by agonist which leads to


reduction in maximal effect which is

Emax and thus reduction in agonist


efficacy another type of antagonist is

called allosteric antagonist unlike the


other ones these bind to the site

different from
agonist binding site and induce

conformational change which prevents


agonist from activating the receptor and

just like with irreversible antagonist


the allosteric ones also cause reduction

in Emax but no change in EC50 the last


important concept in pharmacodynamics
that would like to talk about is
therapeutic index our bodies are very

complex therefore not everyone will


experience the same exact effect from

the same dose of a drug this is why we


came up with therapeutic index as it

helps us to measure the relative safety


of a drug for a particular treatment so

therapeutic index is simply the ratio of


the dose of a drug that produces

toxicity in 50% of the population to the


dose of a drug that produces effective

response in 50% of the population so if


we were to graph it we would need to

determine the curve that represents


positive therapeutic response and the

curve that represents negative toxic


response so in this example after

obtaining data from the population we


can determine dose of a drug at which

we observed effective response in half


of the population which is our ED50

and we can also determine dose of a drug


at which we observed toxic response in

half of the population which is our TD50 now having all that on the graph we

can easily determine therapeutic index


which is this range of doses at which a

drug provides benefits without causing


major toxicity and with that I wanted to

thank you for watching and I hope you


enjoyed this video

You might also like